⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INO News
Inovio Pharmaceuticals, Inc.
Glioblastoma Multiforme (GBM) Market Size, Epidemiology, Competitive Landscape and Forecast to 2036
globenewswire.com
MRK
NVS
LULU
INCY
REGN
INO
INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science
prnewswire.com
INO
Recurrent Head And Neck Squamous Cell Carcinoma Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 65+ Leading Players Wheeling the Therapeutics Landscape
globenewswire.com
GSK
JNJ
MRK
REGN
BIIB
EXEL
IOBT
INO
GMAB
IMUX
NVCR
PDSB
BNTX
CRSP
MRNA
RPTX
PRE
TRNS
INVZ
Form 8-K
sec.gov
INO
Head and Neck Squamous Cell Carcinoma (HNSCC) - Market Insights, Epidemiology, and Market Forecast - 2036 | Set to Reach $2.56 Billion as HPV-Targeted Vaccines Reshape Care
globenewswire.com
MRK
BMY
JNJ
PDS
BNTX
INO
IMPP
CUE
Unlocking Opportunity: Dominate the Cancer Vaccine Market with Confidence Now Available. Tracks 960+ Organizations and 2,100+ Drugs Across the Full Cancer Vaccine Pipeline
globenewswire.com
INO
BNTX
GSK
INOVIO to Participate in Upcoming Investor Conferences
prnewswire.com
INO
Form 8-K
sec.gov
INO
INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights
prnewswire.com
INO
Form 8-K
sec.gov
INO